Q4 2025 Holdings
Filed 2026-02-17 | 86 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $217.6M | 1,250,000 | 10.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $95.6M | 1,200,000 | 4.7% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $91.2M | 1,800,000 | 4.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $89.0M | 1,400,000 | 4.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $81.0M | 105,000 | 4.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $64.8M | 675,000 | 3.2% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $62.3M | 110,000 | 3.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $50.8M | 475,000 | 2.5% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $43.5M | 2,200,000 | 2.2% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $41.1M | 200,000 | 2.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $39.7M | 500,000 | 2.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $37.2M | 1,500,000 | 1.8% |
| Glaukos Corp(GKOS) | COM | 377322102 | $36.7M | 325,000 | 1.8% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $34.5M | 250,000 | 1.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $33.2M | 500,000 | 1.6% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $32.2M | 350,000 | 1.6% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $31.8M | 500,000 | 1.6% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $31.2M | 1,000,000 | 1.5% |
| Penumbra Inc(PEN) | COM | 70975L107 | $31.1M | 100,000 | 1.5% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $30.5M | 250,000 | 1.5% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $28.1M | 750,000 | 1.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $27.7M | 325,000 | 1.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $27.2M | 750,000 | 1.4% |
| Centene Corp del(CNC) | COM | 15135B101 | $26.7M | 650,000 | 1.3% |
| Cooper COS Inc(COO) | COM | 216648501 | $26.6M | 325,000 | 1.3% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $26.3M | 250,000 | 1.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $23.9M | 60,000 | 1.2% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $23.1M | 130,000 | 1.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $21.5M | 900,000 | 1.1% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $21.5M | 20,000 | 1.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $21.5M | 225,000 | 1.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $21.3M | 150,000 | 1.1% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $21.1M | 3,000,000 | 1.0% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $21.0M | 60,000 | 1.0% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $20.4M | 750,000 | 1.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $19.9M | 100,000 | 1.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $19.2M | 90,000 | 1.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $18.4M | 850,000 | 0.9% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $17.7M | 400,000 | 0.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $17.6M | 100,000 | 0.9% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $17.3M | 1,200,000 | 0.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $17.2M | 425,000 | 0.9% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $16.9M | 1,500,000 | 0.8% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $16.5M | 50,000 | 0.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $16.4M | 200,000 | 0.8% |
| Fresenius Medical Care AG(FMS) | SPONSORED ADR | 358029106 | $15.5M | 650,000 | 0.8% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $15.2M | 550,000 | 0.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $15.0M | 325,000 | 0.7% |
| Radnet Inc(RDNT) | COM | 750491102 | $14.3M | 200,000 | 0.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $13.2M | 300,000 | 0.7% |